In vitro activity of tigecycline (GAR-936), a novel glycylcycline, against vancomycin-resistant enterococci and staphylococci with diminished susceptibility to glycopeptides

J Antimicrob Chemother. 2003 Jul;52(1):138-9. doi: 10.1093/jac/dkg289. Epub 2003 Jun 12.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Enterococcus / drug effects*
  • Microbial Sensitivity Tests
  • Minocycline / analogs & derivatives*
  • Minocycline / pharmacology*
  • Staphylococcus / drug effects*
  • Tigecycline
  • Vancomycin / pharmacology
  • Vancomycin Resistance*

Substances

  • Anti-Bacterial Agents
  • Vancomycin
  • Tigecycline
  • Minocycline